GlassScriptPhysician profile
Yelena Laber
NPI 1780779017
$1,003.27
in general payments reported to CMS, 2019-2025
21 companies · $207 in 2025
The $207 reported for 2025 was more than what 81% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.90 · 2022: $152 · 2023: $141 · 2024: $467 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $131.16 | 2024-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Mayne Pharma Commercial LLC | $123.81 | 2022 | |
| Biogen, INC. | $114.40 | 2024 | Zurzuvae |
| Sage Therapeutics, LLC | $107.63 | 2023-2025 | Zurzuvae |
| Astellas Pharma US INC | $83.24 | 2024 | Veozah |
| Janssen Pharmaceuticals, INC | $64.17 | 2021-2022 | |
| Coopersurgical, INC. | $42.35 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $41.90 | 2023-2024 | |
| Shield Therapeutics INC | $41.12 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $33.30 | 2025 | Qelbree |
| Abbott Laboratories | $25.54 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Smith+Nephew, INC. | $24.28 | 2024 | Grafix Pl |
| Bayer Healthcare Pharmaceuticals INC. | $21.96 | 2023 | |
| Exeltis, USA INC. | $21.92 | 2023 | Slynd |
| Novo Nordisk INC | $21.74 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $21.18 | 2024 | Stratafix, Ethicon |
| Mimedx Group, INC. | $20.84 | 2025 | |
| Organon LLC | $18.51 | 2023 | Nexplanon |
| Pacira Pharmaceuticals Incorporated | $15.41 | 2024 | Exparel |
| Abbvie INC. | $14.67 | 2023 | |
| Daiichi Sankyo INC. | $14.14 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yelena Laber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.